FolioLanternBeta
SCTXScribe Therapeutics, Inc.

David Parrot

Chief Financial Officer at Scribe Therapeutics, Inc., as of Jul 27, 2026In the past 12 months: bought $40K of stock in 2 open-market purchases.

Updated Oct 13, 2026 from SEC filings · covers Oct 14, 2025 to Oct 13, 2026
$40K
open-market purchases, past 12 months (2 trades)
1
company filed for

Shares held at Scribe Therapeutics, Inc. is being verified and not shown yet. Why

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Scribe Therapeutics, Inc. (SCTX)Chief Financial OfficerJul 23, 2026Jul 27, 2026

Recent filings

The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.